Integrative genomic analysis facilitates precision strategies for glioblastoma treatment

This publication has 113 references indexed in Scilit:

• Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
  Nucleic Acids Research, 2012
• 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?
  Scientific Reports, 2012
• Random forests for genomic data analysis
  Genomics, 2012
• The sva package for removing batch effects and other unwanted variation in high-throughput experiments
  Bioinformatics, 2012
• Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
  Neuro-Oncology, 2011
• Targeting SRC in glioblastoma tumors and brain metastases: Rationale and preclinical studies
  Cancer Letters, 2010
• ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
  Bioinformatics, 2010
• Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
  Cancer Cell, 2010
• NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas
  Molecular Cancer Therapeutics, 2009
• Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
  Nature Biotechnology, 2008